Identification of Neutrophil Extracellular Traps in Paraffin-Embedded Feline Arterial Thrombi using Immunofluorescence Microscopy
March 29th, 2020
8.3K views
We describe a method to identify neutrophil extracellular traps (NETs) in formaldehyde-fixed and paraffin-embedded feline cardiogenic arterial thrombi using heat-induced antigen retrieval and a double immunolabeling protocol.
Overview
This article presents a protocol for identifying neutrophil extracellular traps (NETs) in feline cardiogenic arterial thrombi. The method utilizes heat-induced antigen retrieval and a double immunolabeling technique to enhance detection in formaldehyde-fixed and paraffin-embedded tissues.
Key Study Components
Area of Science
- Neuroscience
- Veterinary Medicine
- Immunology
Background
- Neutrophil extracellular traps (NETs) are implicated in thrombosis.
- Understanding NETs in feline models can provide insights into thrombotic processes.
- Conventional histological methods may not adequately visualize NETs.
- This protocol aims to improve detection of NETs in veterinary species.
Purpose of Study
- To develop a reliable method for identifying NETs in feline thrombi.
- To assess the role of NETs in feline thrombosis.
- To provide a protocol that can be adapted for other thrombi and species.
Methods Used
- Paraffinization of aortic sections.
- Heat-induced antigen retrieval.
- Double immunolabeling protocol for enhanced visualization.
- Immunofluorescence for simultaneous detection of DNA and proteins.
Main Results
- Successful identification of neutrophil extracellular traps in feline arterial thrombi.
- Immunofluorescence proved superior to conventional histological methods.
- NETs may play a significant role in thrombosis in cats.
- Protocol can be adapted for various thrombi and veterinary species.
Conclusions
- The developed protocol is a valuable tool for studying NETs in veterinary medicine.
- Adjustments to antigen retrieval conditions may enhance signal detection.
- Further research is encouraged to explore NETs in other species.
Frequently Asked Questions
What are neutrophil extracellular traps?
Neutrophil extracellular traps (NETs) are web-like structures released by neutrophils that trap pathogens and can contribute to thrombosis.
Why is this protocol important?
This protocol allows for improved detection of NETs in feline thrombi, which can enhance our understanding of thrombosis in veterinary species.
Can this method be used for other species?
Yes, the protocol can be adapted for use in other veterinary species and types of thrombi.
What is the significance of detecting NETs in thrombi?
Detecting NETs in thrombi suggests they may play a role in the pathophysiology of thrombosis, which is crucial for developing treatment strategies.
How does immunofluorescence compare to conventional methods?
Immunofluorescence allows for simultaneous detection of DNA and proteins, providing a clearer visualization of NETs compared to conventional histological methods.
What adjustments might improve the protocol?
Investigators are encouraged to modify the duration and conditions of the antigen retrieval process to optimize signal detection.
Executive Industry Relevance
This protocol enables detection of neutrophil extracellular traps (NETs) in feline arterial thrombi, offering a mechanistic link between innate immunity and thrombosis in veterinary models. By providing a standardized immunofluorescence method for NET identification in paraffin-embedded tissue, it supports target validation and pathophysiological de-risking in preclinical thrombosis research. The approach may inform translational biomarker development and assay design for thrombotic disorders across species.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of NETs as a potential therapeutic target in thrombosis pathways.
- Operational Value: Provides a reproducible method to validate NET presence in preclinical thrombus models.
Screening & Assay Development
- Scientific Value: Supports development of quantitative immunofluorescence assays for NET biomarkers in thrombi.
- Operational Value: Establishes a standardized workflow for multiplex detection of cfDNA, citH3, and NE in fixed tissue.
Translational & Preclinical Research
- Scientific Value: Facilitates mechanistic de-risking by linking NET formation to thrombus pathology in disease-relevant feline models.
- Operational Value: Enables cross-species assay adaptation for preclinical continuity in thrombosis research.
Pipeline & Workflow Integration
The method fits within the discovery continuum by enabling histopathological validation of NETs following in vitro or in vivo thrombosis induction, supporting lead identification through mechanistic insight.
- Discovery Biology: Supports hypothesis testing of NETs in thrombus formation and fibrinolysis inhibition.
- Screening: Delivers assay-ready tissue preparation with standardized antigen retrieval and multiplex immunofluorescence.
- Analytics: Enables co-localization analysis of cfDNA, citH3, and NE as a quantitative NET readout.
- Translational Research: Connects feline CATE models to human thrombosis pathophysiology through conserved NET mechanisms.
- Enterprise Reuse: Protocol is adaptable to other thrombi and veterinary species, supporting platform scalability.
Operational & Enterprise Impact
- Scientific Value: Mechanistic de-risking of thrombosis targets via direct NET visualization in tissue.
- Operational Value: Standardized deparaffinization, antigen retrieval, and quenching steps ensure reproducibility across labs.
- Strategic Value: Informs go/no-go decisions by clarifying NET contribution to thrombotic risk in preclinical models.
- Portfolio Impact: Enables risk-adjusted prioritization of anti-thrombotic candidates based on NET-modulating activity.
Implementation Considerations
- Requires expertise in immunofluorescence microscopy and multiplex antibody labeling.
- Dependent on antigen retrieval optimization and autofluorescence quenching for signal specificity.
- Necessitates standardized blocking and washing protocols to minimize background and cross-reactivity.
- Adaptation across species may require antibody validation and titration for citH3 and NE detection.
- Practical limitation: NET detection sensitivity is affected by fixation duration exceeding 24 hours.
Biopharma FAQs
Why is co-localization of cfDNA, citH3, and NE required for NET identification?
Co-localization of cell-free DNA, citrullinated histone H3, and neutrophil elastase confirms the presence of authentic neutrophil extracellular traps, distinguishing them from other nuclear or extracellular debris in thrombi.
How does antigen retrieval improve NET detection in paraffin-embedded feline thrombi?
Heat-induced antigen retrieval reverses formaldehyde-induced epitope masking, enabling antibody access to citH3 and NE targets in fixed tissue for reliable immunofluorescence detection.
What quantitative measurements does immunofluorescence enable for NET analysis in thrombi?
Immunofluorescence allows quantitative assessment of NET burden through co-localization intensity and area analysis of cfDNA, citH3, and NE signals in thrombotic sections.
Why are replication requirements important for NET detection in cross-functional thrombosis studies?
Replication ensures consistent NET identification across samples and laboratories, supporting reliable data for target validation and mechanistic de-risking in thrombosis research programs.
What statistical analysis is needed before implementing this NET detection method in preclinical workflows?
Implementation requires co-localization analysis with appropriate thresholds and controls to distinguish specific NET signals from background fluorescence in multiplex immunofluorescence imaging.
Chapters in this video
0:04
Introduction
1:15
Deparaffinization, Rehydration, and Heat-Induced Antigen Retrieval
2:29
Immunolabeling and Autofluorescence Quenching
5:13
Neutrophil Extracellular Trap Identification
6:08
Results: Phase Contrast and Immunofluorescence Images
7:20
Conclusion
